Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma

Haematologica. 2002 Jan;87(1):ELT04.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / secondary
  • Breast Neoplasms / surgery
  • Burkitt Lymphoma / drug therapy
  • Burkitt Lymphoma / pathology
  • Burkitt Lymphoma / therapy*
  • Carcinoma, Intraductal, Noninfiltrating / radiotherapy
  • Carcinoma, Intraductal, Noninfiltrating / surgery
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Immunotherapy*
  • Mastectomy, Segmental
  • Neoplasms, Multiple Primary
  • Orbital Neoplasms / drug therapy
  • Orbital Neoplasms / therapy*
  • Prednisone / administration & dosage
  • Radiotherapy, Adjuvant
  • Remission Induction
  • Rituximab
  • Salvage Therapy
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol